NASDAQ: TOI - The Oncology Institute, Inc.

Yield per half year: -31.2%
Dividend yield: 0.00%
Sector: Healthcare

Share chart The Oncology Institute, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About The Oncology Institute, Inc.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients.

more details
The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-11-15
ISIN US68236X1000
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.theoncologyinstitute.com
Цена ао 1.69
Change price per day: +19.03% (0.2659)
Change price per week: +50.64% (0.2101)
Change price per month: +86.18% (0.17)
Change price per 3 month: +2.23% (0.3096)
Change price per half year: -31.2% (0.46)
Change price per year: -84.49% (2.04)
Change price per 3 year: -95.85% (7.63)
Change price per 5 year: 0% (0.3165)
Change price per 10 year: 0% (0.3165)
Change price per year to date: +75.83% (0.18)
All parameters

Underestimation

Title Value Grade
P/S 0.4617 10
P/BV 2.63 6
P/E 74.91 1
EV/EBITDA -4.36 0
Total: 5.75

Efficiency

Title Value Grade
ROA, % -30.94 0
ROE, % -119.03 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.38

Debt

Title Value Grade
Debt/EBITDA -1.72 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 108.65 10
Yield Ebitda, % -23049.19 0
Yield EPS, % 1705.07 10
Total: 6
More

Institutions Volume Share, %
FMR, LLC 4754083 6.4
Deerfield Management Company, L.P. (Series C) 3360052 4.52
Josh Arnold Investment Consultant, Llc 1856329 2.5
Vanguard Group Inc 1777393 2.39
Balyasny Asset Management LLC 1253037 1.69
Kent Lake Capital, LLC 1085171 1.46
Triatomic Management Lp 884689 1.19
Cincinnati Insurance Company 699500 0.94
TIFF Advisory Services, Inc. 423405 0.57
ELEMENT POINTE ADVISORS, LLC 398052 0.54

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00307 17.09 1.54048



Head Job title Payment Year of birth
Mr. Richard Alan Barasch Chairman of the Board N/A 1954 (71 year)
Mr. Mihir Arunkumar Shah CPA Chief Financial Officer 393.65k 1978 (47 years)
Mr. Jeremy N. Castle M.B.A. Chief Operations Officer N/A 1984 (41 year)
Mr. Mark Hueppelsheuser Esq. General Counsel N/A
Dr. Daniel Virnich FACHE, M.B.A., M.D. CEO & Executive Director 1979 (46 years)
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer 1972 (53 years)
Ms. Laura Szitar Chief People Officer
Mr. Jordan McInerney Chief Development Officer
Mr. Rob Carter Senior Vice President of Finance

Address: United States, Cerritos. CA, 18000 Studebaker Road - open in Google maps, open in Yandex maps
Website: https://www.theoncologyinstitute.com